NetworkNewsBreaks

MondayAug 03, 2026 11:24 am

NetworkNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Completes Homeland Transaction, Retains Significant Upside Through Equity Stake 

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.  MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) completed its previously announced strategic transaction with Homeland Critical Minerals Corp. following CSE clearance, selling its wholly owned subsidiary, MAX Power Resources LLC, which holds the Willcox Playa Lithium Project in Arizona, in exchange for 11 million Homeland common shares valued at approximately C$1.1 million. The stake represents just under 50% of Homeland's outstanding shares, providing MAX Power continued exposure to the Willcox Project while allowing the company to remain focused on advancing its Natural Hydrogen strategy at the Lawson Complex and the broader…

Continue Reading

MondayAug 03, 2026 9:50 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) to Present at OTCQB Virtual Investor Conference

Oncotelic Therapeutics (OTCQB: OTLC) announced that CEO and Chairman Dr. Vuong Trieu will present at the OTCQB Virtual Investor Conference on Aug. 6, 2026, at 2:30 p.m. ET, where investors will have the opportunity to participate in a live question-and-answer session. The company will highlight recent progress, including advancement of its Phase 1b intravenous Everolimus (Sapu003) trial to the next dose cohort, expansion of European clinical sites, validation of its Deciparticle(TM) platform through peer-reviewed publications, scalable cGMP manufacturing capabilities and continued development of its AI-driven drug discovery, robotics and nanomedicine platforms. To view the full press release, visit https://nnw.fm/fGHUt About…

Continue Reading

MondayAug 03, 2026 9:20 am

NetworkNewsBreaks – American Fusion Inc. (OTC: AMFN) Appoints Dr. Noah D’Amico as Strategic Advisor

American Fusion (OTC: AMFN) appointed Dr. Noah D'Amico as a strategic advisor, adding expertise in nuclear diagnostics, radiation measurements, vacuum systems and AI-assisted particle-track analysis as the company advances the next phase of its Texatron(TM) Fusion Engine(TM) testing program at Texas Tech University. D'Amico, who serves as lead engineer in Texas Tech University's Department of Physics & Astronomy and chief operating officer of BlankSlate Innovation, will support laboratory preparation, experimental planning, instrumentation, data collection and technical documentation. The company said the appointment strengthens its scientific and engineering capabilities as it continues development and testing of the Texatron fusion platform. To…

Continue Reading

MondayAug 03, 2026 9:00 am

NetworkNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Michael Halstead as CEO

This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising. Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) appointed Michael Halstead as chief executive officer, effective immediately, as the clinical-stage company advances HLP003 through Phase 3 development and prepares for potential commercialization. Halstead, who most recently served as president of Intra-Cellular Therapies, brings 25 years of biopharmaceutical leadership experience, including overseeing the development and commercialization of CAPLYTA(R), supporting pipeline expansion and helping lead the company's $14.6 billion acquisition by Johnson & Johnson in 2025. His appointment comes with enrollment complete in the Phase 3 APPROACH trial,…

Continue Reading

FridayJul 31, 2026 3:49 pm

NetworkNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Advances Regenerative Solution for Major Unmet Need in Cartilage Repair

Regentis Biomaterials (NYSE American: RGNT) was featured in a recent article that discussed its efforts to advance GelrinC, a potentially first-in-class, off-the-shelf cartilage regeneration platform, and the company’s broader mission to establish a new standard of care in cartilage repair. “Regentis is developing regenerative biomaterial technology as healthcare shifts toward therapies designed to restore damaged tissue rather than simply manage symptoms. With cartilage defects affecting hundreds of thousands of patients each year and contributing to pain, reduced mobility, and degenerative joint disease, the company is targeting one of orthopedic medicine’s largest unmet needs,” reads the article. “GelrinC’s commercial potential is rooted in…

Continue Reading

FridayJul 31, 2026 3:34 pm

NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances MS Imaging Study with Encouraging Preliminary Results

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) has reached the halfway point in patient enrollment for its pilot MS imaging study with Massachusetts General Hospital, with preliminary PET imaging data showing encouraging signals in acute MS lesions. The novel imaging technique is designed to distinguish demyelinated nerve fibers that may still be viable from permanent nerve damage, potentially offering a more precise way to measure myelin loss and repair. “These findings are directly relevant to Lucid-MS, the company’s investigational compound designed to inhibit demyelination by targeting the enzyme PAD2, which…

Continue Reading

FridayJul 31, 2026 3:16 pm

NetworkNewsBreaks – Greenland Energy Company (NASDAQ: GLND) Targets Arctic Oil Potential as Global Energy Security Takes Center Stage

Greenland Energy (NASDAQ: GLND) is advancing exploration of Greenland’s Jameson Land Basin, a large undrilled Arctic petroleum basin that combines historical exploration data, modern seismic analysis and significant prospective resource potential. The company’s focus on Greenland’s stable, Western-aligned jurisdiction adds strategic value as global energy security concerns increase. With approximately 2.1 million acres under license, an estimated $81 million raised to fund its initial two-well program and drilling preparations underway, Greenland Energy expects to begin drilling the OPW-1 well in the fourth quarter of 2026. Although exploration and commercial risks remain, the project represents a potentially significant opportunity to develop new…

Continue Reading

FridayJul 31, 2026 12:25 pm

NetworkNewsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Signs AT&T Fiber Agreement for 500 MW Texas AI Campus

AZIO AI Holdings (NASDAQ: AZIO) announced it has executed a master services agreement with AT&T to provide enterprise fiber connectivity for its planned 500-megawatt Texas AI infrastructure platform. The agreement establishes a standardized, high-capacity networking framework designed to support AI training, inference, GPU cloud computing, enterprise colocation and other high-performance computing workloads. Under the agreement, AZIO AI has committed approximately $2.4 million for fiber services, with the connectivity infrastructure intended to accelerate deployment for potential hyperscale customers and support the company's long-term strategy of building scalable, LNG energy-backed AI data center capacity. To view the full press release, visit https://nnw.fm/YwLcJ…

Continue Reading

FridayJul 31, 2026 10:17 am

NetworkNewsBreaks – Greenland Mines Ltd. (NASDAQ: GRML) Launches 2026 Field Season at Skaergaard Project 

Greenland Mines (NASDAQ: GRML) announced the start of its 2026 field season at the Skaergaard Project as its support vessel, Argus, departed Reykjavik, Iceland, for southeast Greenland carrying drill rigs, geophysical equipment, drone survey systems, bulk-sampling machinery, fuel and other exploration infrastructure. The initial field team includes more than 40 technical experts, drillers and logistics personnel, with additional specialists scheduled to rotate in throughout the season. The program encompasses resource drilling, bulk sampling, environmental baseline studies, geotechnical and engineering work, and advanced aerial and ground-based surveys designed to support a resource upgrade and advance the project toward its next development phase, including evaluation of a potential initial open-pit mining scenario alongside existing underground mining concepts. To view the…

Continue Reading

FridayJul 31, 2026 9:20 am

NetworkNewsBreaks – Frontieras North America Announces Regulation A+ Share Price Increase Following Commercial Milestones

Frontieras North America announced that the share price for its Regulation A+ offering will increase after Aug. 6, 2026, reflecting investor demand and commercial progress since the offering reopened July 1 at $9.01 per share. The current price remains available to accredited and non-accredited investors who complete their investment by 11:59 p.m. PT on Aug. 6. The company highlighted several milestones supporting the valuation increase, including fully subscribing its initial $25.7 million Regulation A+ offering, expanding the offering to the $75 million statutory maximum, breaking ground on its planned $850 million FASForm(TM) facility in West Virginia, securing a $150 million…

Continue Reading